Blog
FDA Expands Dupixent Approval for Adolescents with Chronic Rhinosinusitis with Nasal Polyps, Leveraging RWE Powered by Aetion® Substantiate
Blog authored by:
Blog
Driving Innovation in HTA Decision-Making: Aetion participates in RWE4Decisions' 2024 Stakeholder Actions
On November 14th, RWE4Decisions hosted its annual Symposium, this year focusing on how to ...
Blog
Own the Future of Healthcare: Aetion’s AI/ML Tools Turn Data Into Impact
Healthcare stands at a crossroads. The pressure to deliver better care at lower costs is ...
On-Demand Webinar
Frameworks and Tools for Generating Decision-Grade RWE | Jan 12, 2023
Watch the webinar Frameworks and Tools for Generating Decision-Grade RWE to explore ...
Blog
Applying AI to RWE and Drug Development
With applications abound, AI is poised to change how RWD/RWE teams operate and how ...
Blog
What’s Next for Healthcare in 2025: Emerging Threats, GLP-1 Inhibitors, AI, and the Power of RWE
As 2024 comes to a close and 2025 gets going, major changes in healthcare and drug ...
Publication
Evaluating Real-World Use of Botulinum Toxins for Cervical Dystonia, Blepharospasm, and Hemifacial Spasm
Movement disorders like cervical dystonia, blepharospasm, and hemifacial spasm can ...
Publication
Understanding Clinical Profiles and Treatment Approaches in Chronic Sialorrhea: A Real-World Study
Chronic sialorrhea, and underdiagnosed and poorly understood condition marked by ...
Blog
How RWE can Impact R&D and Beyond
Real-world data (RWD) and real-world evidence (RWE) continue to positively impact drug ...
Blog
Bringing Patients Front and Center in RWD/RWE
The ultimate goal of using real-world data (RWD) to generate real-world evidence (RWE) is ...
Publication
Use of transportability methods for real-world evidence generation: A review of current applications
A recent study investigated whether and how statistical techniques, referred to as ...
Publication
Calibrating Observational Health Record Data Against a Randomized Trial
A first-of-its-kind cross-industry initiative, the Aetion CARE Initiative brings together ...
Publication
Evaluating the Effectiveness of a Third COVID-19 Vaccine Dose in Immunocompromised Adults
As the immunocompromised population faces heightened risks from COVID-19, understanding ...
Publication
Hypertension Risk in Narcolepsy Patients Using Sodium Oxybate: A Real-World Study
Managing narcolepsy often requires the use of specialized medications, but understanding ...
Blog
Webinar recap: The Goldilocks problem in oncology RWD: choosing the data that’s ‘just right’
We all know that, in the story of Goldilocks and the Three Bears, it took the young girl ...
Blog
Advancing Pharmacoepidemiology at ICPE 2024
Aetion joins experts from around the world at ICPE 2024 to discuss advances in ...
Publication
Understanding the Economic Burden of RSV-Associated Hospitalizations in Adults
Respiratory syncytial virus (RSV) poses significant health risks, particularly for older ...
Publication
Comparing the Effectiveness of a Third COVID-19 Vaccine Dose in Older Adults
As the COVID-19 pandemic continues to evolve, the importance of booster doses in ...
Podcast
Podcast: Top leadership share stories of their childhood and how it guided them into leadership roles later in life
In this episode of the Executive Leaders Radio Podcast, John Ferretti of CODi, Carolyn ...
Blog
Efficient Synthesis of Complex Health Data
Blog authored by Lucy Mosquera (Sr. Director, Generate Operations and Data Science) and ...
Blog
Advancing SMA Treatment: How Real-World Evidence Supports Regulatory Decisions
Spinal Muscular Atrophy (SMA) is a rare and debilitating neuromuscular disease affecting ...
Blog
Quality, Rigor, and Transparency: The RWE Imperative
Over the past year, news stories have focused on high-profile missteps or fraud in the ...
Blog
The Evolving Role of Observational Studies in Healthcare: Enhancing Payer Utility and Impact
Blog authored by Ashley Jaksa (VP, Scientific Strategy & Partnerships) and Pat Arena ...
Publication
The potential role of real-world evidence in Centers for Medicare & Medicaid Services’ future price negotiations: Recommendations for a robust framework
In this article, authors Ashley Jaksa (VP, Scientific Strategy & Partnerships, ...